Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects Publication Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects Explore how food affects absorption; liver enzymes and creatinine influence clearance in valsartan PopPK using…CertaraOctober 26, 2022
3 takeaways from the FDA oligo guidance you need to know Blog 3 takeaways from the FDA oligo guidance you need to know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…CertaraSeptember 23, 2022
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach Publication Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach Discover how species differences in PK and metabolite ratios explain efficacy variation using Phoenix WinNonlin.CertaraSeptember 11, 2022
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients Publication Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients See how early clearance drop predicts better response and survival; PopPK built using Phoenix NLME.CertaraSeptember 6, 2022
Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients Publication Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients Learn how creatinine clearance and ALT drive PK; simulations show need for adjusted dosing using…CertaraAugust 29, 2022
Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction. Publication Pharmacokinetic Study of Nalbuphine in Surgical Patients Undergoing General Anesthesia with Varying Degrees of Liver Dysfunction. Find out how Liver dysfunction increases nalbuphine half‑life and Vd; PK analysed using Phoenix WinNonlin.CertaraJuly 26, 2022
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World Patients Publication Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World Patients Explore how model predicts population‑level target attainment but large individual variability using Phoenix NLME.CertaraJuly 25, 2022
Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial. Publication Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial. Discover how itraconazole markedly increases SHR2554 exposure; PK interaction assessed using Phoenix WinNonlin.CertaraJuly 16, 2022
CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response. Publication CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response. See how CYP2A6 affects exposure; GABRA2 predicts heart‑rate abnormalities using Phoenix NLME.CertaraJuly 7, 2022